What is Astrana Health Inc's share price today?
Astrana Health Inc (ASTH) share price today is $38.99 as of November 6, 2026 at 12:24 AM IST. The stock touched a day high of $40.84 and a day low of $38.43.What exchange does Astrana Health Inc stock trade on, and under what ticker symbol?
Astrana Health Inc stock trades on NASDAQ under the ticker symbol ASTH.What is Astrana Health Inc's market capitalization?
Astrana Health Inc's market capitalization is $1.82B as of November 6, 2026 at 12:24 AM IST.What is Astrana Health Inc's price-to-earnings (P/E) ratio?
Astrana Health Inc's price-to-earnings (P/E) ratio is 44.25 as of November 5, 2026.What is Astrana Health Inc's price-to-book (P/B) ratio?
Astrana Health Inc's price-to-book (P/B) ratio is 2.20 as of November 5, 2026.Can Indian investors buy Astrana Health Inc shares?
Yes, You can buy Astrana Health Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Astrana Health Inc shares from India?
Indian investors can buy Astrana Health Inc shares in three steps: 1. Search Astrana Health Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Astrana Health Inc shares for Indian investors?
Since Astrana Health Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Astrana Health Inc shares via Tickertape?
Indian investors can start investing in Astrana Health Inc (ASTH) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.2564 shares at the current price of $38.99.
Key Metrics
Key Metrics
Close price divided by the earnings per share for the trailing twelve months
Close price divided by the book value per share at the end of the most recent quarter
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
Net profit divided by the total revenue for the most recent financial year
Annual dividend per share for the trailing twelve months divided by the close price
Based on 11 analysts reports
Price Upside
+40.67%
Earnings Growth
+77.85%
Rev. Growth
+25.15%
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
All values in $
All values in $
Revenue Forecast
Revenue Forecast
The next fiscal year's mean estimate implies 25.15% growth, versus a trailing 3-year CAGR of 40.62%.
All values in $ Billion
All values in $ Billion
Earnings Per Share Forecast
Earnings Per Share Forecast
The next fiscal year's mean estimate implies 77.85% growth, versus a trailing 3-year CAGR of 17.61%.
All values in $
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 404.35 | 486.26 | 478.71 | 665.20 | 620.39 | 654.80 | 956.04 | 950.52 | 965.1 | 972.52 |
| Gross Profit | 68.86 | 66.01 | 73.49 | 63.01 | 71.32 | 77.96 | 81.59 | 78.64 | 90.26 | 104.02 |
| Net Income | 14.83 | 19.17 | 16.09 | -6.95 | 6.69 | 9.42 | 0.37 | 5.99 | 14.43 | 19.73 |
| Net Profit Margin | 3.66% | 3.94% | 3.36% | -1.04% | 1.07% | 1.43% | 0.03% | 0.63% | 1.49% | 2.02% |
Peers
Peers & Comparison
Peers & Comparison
HealthcareMedical Care Facilities
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Astrana Health Inc | 44.25 | 2.20 | 0 |
| CVS Health Corp | 24.05 | 1.42 | 0.20 |
| The Cigna Group | 12.21 | 1.84 | 0.81 |
The 12-month consensus target implies 40.67% growth, versus a trailing 3-year CAGR of 7.78%.